THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
Earlier this month, we spoke with Irene, a patient representative in EU PAL COPD and a member of the European Lung Foundation COPD Patient Advisory Board. She told us about how she became involved in the project and why it is important to her.
Could you please tell us a little bit about yourself?
My name is Irene, I’m 77 years old and I come from the East of England. I have a master’s degree in social research methodology. I worked as a Service Manager in social work in childcare and child protection. When I retired, I worked in the research arm of our NHS as a patient reviewer of health research for 15 years. In the early days this was difficult as there was a reluctance for patients to be involved but now this has been resolved and for the most part patients’ views are seen as integral to research.
How did you get involved with the EU COPD PAL project?
I personally knew a researcher from Lancaster University in the UK, who is involved in the EU PAL COPD project. 18 months ago, when I found out about my condition, she invited me to join the project as a patient to help bring the patient voice to research.
How have you engaged in the project so far?
It feels like the project is in its early stages, so at first, we are just sharing our experiences about COPD. So far, we have attended 2 meetings with researchers where we could say what was important to us as COPD patients. I felt that our opinion mattered a lot, because in the early days of my career as a patient engagement specialist I learned to see when patients are not taken seriously. This is not the case here.
Why are you interested in this project?
Firstly, I am a patient myself. Secondly, as the project has a global reach, I was interested to learn about the many similarities in different European countries, although not all the services are the same. The project can help us learn from each other’s experience and improve palliative care for COPD patients from different countries.
The project is about quite a sensitive topic – how do you personally feel about participating in it?
I think that as a patient in this project you have to be dispassionate because it is not about you and it’s not about answering questions about your health. It is more about the experience you can share with the research to help patients with similar conditions.
Was there anything challenging/difficult about participating in the project?
I would say that it is difficult for me to hear the stories of people who are struggling. It’s also upsetting when I know that someone’s condition is close to mine – but I try to separate myself from it.
There were many different people from all over Europe at the meetings – how was it?
I am interested to hear about their experiences. It’s nice to find similarities in different contexts. Patients suffer from the same problems with medicines in different healthcare systems. For example, now I can compare our healthcare system, which I consider to be somewhat paternalistic, with the Belgian one, which I have heard is more liberal.
What do you hope happens in the future as a result of this project?
As we look at palliative care for COPD patients, I hope that we can integrate it as part of COPD treatment for those patients who need it. I hope this project will help them make the right choice if they want palliative care. There is so much uncertainty for people with this disease, but making an informed decision about their treatment is something that every patient should have the right to do. I haven’t made a decision yet myself, but I hope that participating in this project will also help me decide what is best for me.
Why it is important that patients are involved in projects like this? What do patients bring to research?
I believe that patients have a say and have a unique perspective based on the experiences we have every day. When we represent different countries, we can share best practices in treatment to contribute to the idea of the most appropriate form of care.
Is there anything you would like to add?
For me, in general, participating in the project is very exciting because I like to see other patients, it’s interesting to hear stories about how similar we are in what we are going through. I especially like working with the researchers. I have a friend in the research team who I respect and trust, and I can talk freely about my condition and how I feel.
If you are interested in joining the ELF COPD PAG and getting involved in research projects like EU PAL COPD and others, please get in touch with us: https://europeanlung.org/en/contact-us/
Prepared by the EU PAL-COPD partners, Lungs Europe.
The information you provide will only be used for newsletter campaigns by EU PAL-COPD. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s terms of use. You can unsubscribe at any time by clicking the link in the footer of our emails. Read our privacy policy to learn how your data is used.
EU PAL-COPD is funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them [grant number 101136621]. This project is also supported by the UK Research and Innovation (UKRI) [grant numbers 10109731 and 10109782], the Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund [grant number 2020-2.1.1-ED-2023-00260], and the Swiss State Secretariat for Education, Research and Innovation (SERI).
© 2024 accelopment Schweiz AG · info@accelopment.com · ISO 9001 certified · Read our Privacy Policy and Cookie Policy
Stay informed about latest EU PAL-COPD results and milestones.